Sphera Funds Management Ltd. Akero Therapeutics, Inc. Transaction History

Sphera Funds Management Ltd.

  • $545 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$18.31 - $24.62 $344,685 - $463,471
-18,825 Reduced 11.73%
141,620 $3.32 Million
Q1 2024

May 15, 2024
BUY
$17.76 - $31.18 $2.85 Million - $5 Million
160,445 New
160,445 $4.05 Million
Q4 2019

Feb 13, 2020
SELL
$17.37 - $27.27 $2.26 Million - $3.55 Million
-130,000 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$16.89 - $29.88 $2.2 Million - $3.88 Million
130,000 New
130,000 $2.96 Million

Others Institutions Holding AKRO

# of Institutions
190
Shares Held
73.8M
Call Options Held
241K
Put Options Held
647K
View Full List

About Akero Therapeutics, Inc.

AKRO Quotes by TradingView
  • Ticker AKRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,417,600
  • Market Cap $1.52B
  • Description
  • Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...
More about AKRO
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email